Commercialization Phase Clause Samples

Commercialization Phase. The second phase of the Commercialization ----------------------- Program shall be the Commercialization Phase, during which GE and CCSI will jointly pursue the Commercialization of the Products as developed during the Technology Development Phase. GE and CCSI will conduct their respective efforts in accordance with the Commercialization Plan attached hereto as Exhibit B, as such Commercialization Plan may be modified by the Management Committee under Section 5.1.3 below, Article 7, and any other relevant terms of this Agreement.
Commercialization Phase. 12 2.3 Accounting and Internal Controls................................14 2.4 Restrictions....................................................15
Commercialization Phase. To the extent that during the Commercialization Phase, A▇▇▇▇ requires consulting work from Quick-Med for other work due to requests made by A▇▇▇▇ (and accepted by Quick-Med), then the rate for such work shall be at $2,000 per day per person or fraction thereof at $250 per hour. In addition, the reasonable out-of-pocket expenses for food, lodging, travel, and consumables incurred and for third party expenses (including, without limitation, independent third party consultants and laboratory expenses) incurred by Quick-Med will be separately billed as incurred and paid by A▇▇▇▇, subject to A▇▇▇▇’▇ approval of the expenses before they are incurred and the submission to A▇▇▇▇ of evidence of such out-of-pocket expenses in form and substance reasonably satisfactory to A▇▇▇▇. All invoices shall be paid within thirty (30) days of the date thereof.
Commercialization Phase. If Licensee requests Meiji to supply the Bulk during the period of Product commercialization, Meiji shall do so, subject to the terms and conditions of a separate supply agreement to be negotiated in good faith and executed at the time of such request by Licensee. Such separate agreement shall be consistent with the applicable terms of the Agreement, will contain commercially reasonable terms and conditions as are necessary and appropriate for such a supply agreement, and shall incorporate the following terms among others: (x) Licensee shall pay not less than [ * ] for the first [ * ] of the Bulk supplied each year for commercial use, and (y) if Licensee requests more than [ * ] per year, the separate agreement shall assure the price of the Bulk not less than [ * ] and compensation to Meiji for its capital investment (if any) necessary to increase its manufacturing capacity to supply Licensee's requirements. Unless such separate agreement is executed by the date of the First Commercial Sale of Product in the United States or Europe, whichever is earlier, Meiji shall have no subsequent obligations to supply the Bulk for commercial use.
Commercialization Phase. Bayer shall use commercially reasonable efforts during the Commercialization Phase to successfully market each Metabolic Program Drug; provided, however that the decision how to market and whether to continue to market such Metabolic Program Drug shall be up to Bayer in its sole discretion. Article III ----------- Bayer and CuraGen Rights and Obligations ---------------------------------------- Section 3.1 License Grant with Respect to CuraGen Know-How and CuraGen ---------------------------------------------------------- Patent Rights. -------------
Commercialization Phase. The second phase of the Commercialization ----------------------- Program shall be the Commercialization Phase, during which GE and CCSI will jointly pursue the Commercialization of the Products as developed during the Technology THE SYMBOL "[*]" IS USED TO INDICATE THAT A PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. Development Phase. GE and CCSI will conduct their respective efforts in accordance with the Commercialization Plan attached hereto as Exhibit B, as such Commercialization Plan may be modified by the Management Committee under Section 5.1.3 below, Article 7, and any other relevant terms of this Agreement.
Commercialization Phase. 30 new jobs created (Scientific, Production, Support) SALES: This product will increase HYDROGENICS' sales by 30% (by $3M) by 2001.
Commercialization Phase. If Licensee requests Meiji to supply the Bulk during the period of Product commercialization, Meiji shall do so, subject to ---------- [*] Confidential Treatment Requested the terms and conditions of a separate supply agreement to be negotiated in good faith and executed at the time of such request by Licensee. Such separate agreement shall be consistent with the applicable terms of the Agreement, will contain commercially reasonable terms and conditions as are necessary and appropriate for such a supply agreement, and shall incorporate the following terms among others: (x) Licensee shall pay not less than [*] for the first [*] of the Bulk supplied each year for commercial use, and (y) if Licensee requests more than [*] per year, the separate agreement shall assure the price of the Bulk not less than [*] and compensation to Meiji for its capital investment (if any) necessary to increase its manufacturing capacity to supply Licensee's requirements. Unless such separate agreement is executed by the date of the First Commercial Sale of Product in the United States or Europe, whichever is earlier, Meiji shall have no subsequent obligations to supply the Bulk for commercial use.
Commercialization Phase 

Related to Commercialization Phase

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in ▇▇▇▇▇, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones) B. Estimated total development time

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.